Massachusetts-based Deciphera Pharmaceuticals (DCPH) is a clinical-stage biopharmaceutical company developing drugs to improve the lives of cancer patients. Its current pipeline is comprised of three drugs DCC-2618, DCC-3014 and Rebastinib….
Continue Reading »